Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Dual Bronchodilator Therapy in COPD Patients Undergoing Lung Cancer Surgery
NCT04536675Phase 3Active, not recruiting
- Sponsor
- Samsung Medical Center
- Start
- Apr 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vilanterol, umeclidinium in chronic obstructive pulmonary disease (COPD), sponsored by Samsung Medical Center. Started Apr 2021; status: active, not recruiting.
02
Drugs
vilanterolumeclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04536675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536675.